Switch theme
Sign up to access all valuation multiples
Zenicor Medical Systems AB is a medical technology company. It is engaged in remote diagnosis of cardiac care and stroke prevention.
2003
15
Last FY Revenue $2.6M
Last FY EBITDA $0.5M
$3.5M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Zenicor Medical Systems achieved revenue of $2.6M and an EBITDA of $0.5M.
Zenicor Medical Systems expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Zenicor Medical Systems valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $2.6M | XXX | XXX | XXX |
| Gross Profit | XXX | $2.9M | XXX | XXX | XXX |
| Gross Margin | XXX | 111% | XXX | XXX | XXX |
| EBITDA | XXX | $0.5M | XXX | XXX | XXX |
| EBITDA Margin | XXX | 18% | XXX | XXX | XXX |
| EBIT | XXX | $13K | XXX | XXX | XXX |
| EBIT Margin | XXX | 0% | XXX | XXX | XXX |
| Net Profit | XXX | -$0.2M | XXX | XXX | XXX |
| Net Margin | XXX | -8% | XXX | XXX | XXX |
| Net Debt | XXX | $1.9M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Zenicor Medical Systems's stock price is SEK 2 (or $0).
Zenicor Medical Systems has current market cap of SEK 22.6M (or $2.3M), and EV of SEK 33.8M (or $3.5M).
See Zenicor Medical Systems trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $3.5M | $2.3M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Zenicor Medical Systems has market cap of $2.3M and EV of $3.5M.
Zenicor Medical Systems's trades at 1.3x EV/Revenue multiple, and 7.6x EV/EBITDA.
Equity research analysts estimate Zenicor Medical Systems's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Zenicor Medical Systems's P/E ratio is not available.
See valuation multiples for Zenicor Medical Systems and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2.3M | XXX | $2.3M | XXX | XXX | XXX |
| EV (current) | $3.5M | XXX | $3.5M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 1.3x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | 7.6x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | 268.3x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | -10.8x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -4.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialZenicor Medical Systems's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.2M for the same period.
Zenicor Medical Systems's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Zenicor Medical Systems's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Zenicor Medical Systems and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | 18% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 111% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Zenicor Medical Systems acquired XXX companies to date.
Last acquisition by Zenicor Medical Systems was XXXXXXXX, XXXXX XXXXX XXXXXX . Zenicor Medical Systems acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Zenicor Medical Systems founded? | Zenicor Medical Systems was founded in 2003. |
| Where is Zenicor Medical Systems headquartered? | Zenicor Medical Systems is headquartered in Sweden. |
| How many employees does Zenicor Medical Systems have? | As of today, Zenicor Medical Systems has 15 employees. |
| Is Zenicor Medical Systems publicy listed? | Yes, Zenicor Medical Systems is a public company listed on SAT. |
| What is the stock symbol of Zenicor Medical Systems? | Zenicor Medical Systems trades under ZENI ticker. |
| When did Zenicor Medical Systems go public? | Zenicor Medical Systems went public in 2014. |
| Who are competitors of Zenicor Medical Systems? | Similar companies to Zenicor Medical Systems include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Zenicor Medical Systems? | Zenicor Medical Systems's current market cap is $2.3M |
| Is Zenicor Medical Systems profitable? | Yes, Zenicor Medical Systems is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
